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a well-known potential complication of bisphosphonate
treatment. The clinical findings of BRONJ may vary in pa-
tients, including exposed necrotic bone, which can be
accompanied by pain, swelling, paresthesia, pus discharge,
and soft tissue ulceration. Currently, the management of
BRONJ remains controversial, and there is no definitive
treatment other than the standard protocol. Choukroun’s
platelet-rich fibrin (PRF) represents a relatively new
biotechnology for the stimulation and acceleration of tissue
healing and bone regeneration.1 In this study, we report a
BRONJ patient who was treated with surgical debridement,
sequestrectomy, and simultaneous reconstruction using PRF
as the sole grafting material.
A 79-year-old woman was referred in July 2011 by a
local dental clinic for a painful jaw bone lesion. Her
medical history included osteoporosis since 1996, which
was treated weekly with alendronate (Fosamax, 70 mg,
per os; Merck, Whitehouse Station, NJ, USA) for 10 more
years, and intravenous zoledronic acid (Aclasta; Norvatis
Pharmaceuticals, Frimley, Camberley, UK) infusions
annually, at a dose of 5 mg, from 2010 to 2011. The
intraoral examination revealed a diffuse, tender,
erythematous swelling over the edentulous area at the
right posterior mandible with a purulent dischargeConflicts of interest: The authors have no conflicts of interest
relevant to this article.
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in the right posterior mandible (Figure 1B). According to
the patient’s clinical and radiological findings, the diag-
nosis was BRONJ stage 3. Medical therapy with ciproflox-
acin (750 mg/d) and chlorhexidine mouthwashes were
prescribed for 3 months. Then, the patient received sur-
gical sequestrectomy and saucerization (Figure 1C) under
general anesthesia with simultaneous reconstruction with
PRF. PRF clots and membranes were prepared according to
the Choukroun procedure.1 PRF was packed into the sur-
gical defect (Figure 1D). The overlying mucosa was su-
tured tension free with PRF membranes. After 10 days,
postoperative healing was uneventful with no signs of
infection or wound dehiscence (Figure 1E). Panoramic
tomography showed new bone regeneration and no sign of
necrotic bone after 10 months of follow-up (Figure 1E).
The patient was still regularly followed up in our clinic. No
new oral lesion was observed.
Recently, we reported that the use of PRF as sole filling
material applied in simultaneous sinus lift and implantation
demonstrated a new bone formation in the augmented
areas.2 In this case, the application of PRF for BRONJ also
revealed total bone closure and new bone regeneration.
The mechanism responsible for the osteoblasts by PRF may
be explained as follows. Previously, PRF was found to be
capable of increasing osteoblast attachment, growth, pro-
liferation, and simultaneously upregulating osteoprotegerin
and collagen-related protein production.3e5 These actions
in combination may effectively promote bone regenera-
tion. Taken together, PRF could be an easily prepared and
effective material for the closure of BRONJ. Theby Elsevier Taiwan LLC. This is an open access article under the
/4.0/).
Figure 1 Clinical and radiographic photographs of the affected area. (A) Initial intraoral view showing the exposed necrotic bone
and pronounced mucosal ulceration over the right posterior mandibular edentulous area caused by BRONJ. (B) Sequestration was
obvious in the right posterior mandibular edentulous area shown on an initial panoramic tomographic scan. (C) The sequestrum was
removed by surgical sequestrectomy and saucerization. (D) Clinical application of PRF as the sole grafting material in bony lesion.
(E) Clinical photograph of the lesion with PRF coverage after 10 days. (F) Postoperative panoramic radiograph revealed dense
bonelike tissues over the right posterior mandibular edentulous area 10 months after the surgery. BRONJZ bisphosphonate-related
osteonecrosis of the jaw; PRF Z platelet-rich fibrin.
586 L.-L. Tsai et al.application of PRF may be an alternative method to
enhance bone healing for the treatment of BRONJ.
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